{"entity":{"type":"insider","cik":"0001873392","url":"/insider/0001873392","json_url":"/insider/0001873392.json","name":"Dowden Nathan J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":17,"first":"2022-06-29","last":"2026-05-04","span_basis":"filed_date"},"name_variants":[{"name":"Dowden Nathan J","source":"filing","n_filings":17,"first_seen":"2022-06-29","last_seen":"2026-05-04"}],"transactions":[{"id":5852640,"accession":"0001873392-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001873392-26-000004","line_url":"/filing/0001873392-26-000004#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.3302,"price_display":"15.33","price_state":"stated","total_value":229953.0,"total_display":"229,953.00","total_whole":"229,953","shares_owned_after":198588.0,"shares_owned_after_display":"198,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-04","scope":"insider"},{"id":6120749,"accession":"0001873392-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001873392-26-000002","line_url":"/filing/0001873392-26-000002#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11894.0,"shares_display":"11,894","price_per_share":13.0476,"price_display":"13.05","price_state":"stated","total_value":155188.1544,"total_display":"155,188.15","total_whole":"155,188","shares_owned_after":198588.0,"shares_owned_after_display":"198,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":6120746,"accession":"0001873392-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001873392-26-000002","line_url":"/filing/0001873392-26-000002#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3116.0,"shares_display":"3,116","price_per_share":13.024,"price_display":"13.02","price_state":"stated","total_value":40582.784,"total_display":"40,582.78","total_whole":"40,583","shares_owned_after":210482.0,"shares_owned_after_display":"210,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":2571423,"accession":"0001689375-24-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000056","line_url":"/filing/0001689375-24-000056#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":847.0,"shares_display":"847","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":13552.0,"total_display":"13,552.00","total_whole":"13,552","shares_owned_after":125149.0,"shares_owned_after_display":"125,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":2366186,"accession":"0001689375-24-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000054","line_url":"/filing/0001689375-24-000054#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1904.0,"shares_display":"1,904","price_per_share":15.0684,"price_display":"15.07","price_state":"stated","total_value":28690.2336,"total_display":"28,690.23","total_whole":"28,690","shares_owned_after":125996.0,"shares_owned_after_display":"125,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-10","scope":"insider"},{"id":2366183,"accession":"0001689375-24-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000054","line_url":"/filing/0001689375-24-000054#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":15.1947,"price_display":"15.19","price_state":"stated","total_value":6062.6853,"total_display":"6,062.69","total_whole":"6,063","shares_owned_after":127900.0,"shares_owned_after_display":"127,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":2523178,"accession":"0001689375-24-000048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-24-000048","line_url":"/filing/0001689375-24-000048","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27097.0,"shares_display":"27,097","price_per_share":16.267525519430194,"price_display":"16.27","price_state":"stated","total_value":440801.139,"total_display":"440,801.14","total_whole":"440,801","shares_owned_after":130609.0,"shares_owned_after_display":"130,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2165152,"accession":"0001689375-24-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000007","line_url":"/filing/0001689375-24-000007#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (President & COO)","role_mark":"O","role_mark_label":"Officer (President & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1826.0,"shares_display":"1,826","price_per_share":12.3213,"price_display":"12.32","price_state":"stated","total_value":22498.6938,"total_display":"22,498.69","total_whole":"22,499","shares_owned_after":137204.0,"shares_owned_after_display":"137,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-08","scope":"insider"},{"id":8488950,"accession":"0001689375-23-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-23-000061","line_url":"/filing/0001689375-23-000061","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":972.0,"shares_display":"972","price_per_share":13.46614475308642,"price_display":"13.47","price_state":"stated","total_value":13089.0927,"total_display":"13,089.09","total_whole":"13,089","shares_owned_after":48227.0,"shares_owned_after_display":"48,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider","n_lines":2},{"id":8511911,"accession":"0001689375-23-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000047","line_url":"/filing/0001689375-23-000047#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3897.0,"shares_display":"3,897","price_per_share":18.048,"price_display":"18.05","price_state":"stated","total_value":70333.056,"total_display":"70,333.06","total_whole":"70,333","shares_owned_after":35376.0,"shares_owned_after_display":"35,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-12","scope":"insider"},{"id":8511905,"accession":"0001689375-23-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000047","line_url":"/filing/0001689375-23-000047#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":18.0016,"price_display":"18.00","price_state":"stated","total_value":57605.12,"total_display":"57,605.12","total_whole":"57,605","shares_owned_after":39273.0,"shares_owned_after_display":"39,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-12","scope":"insider"},{"id":8130522,"accession":"0001689375-23-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000042","line_url":"/filing/0001689375-23-000042#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7097.0,"shares_display":"7,097","price_per_share":16.0208,"price_display":"16.02","price_state":"stated","total_value":113699.6176,"total_display":"113,699.62","total_whole":"113,700","shares_owned_after":42473.0,"shares_owned_after_display":"42,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-22","scope":"insider"},{"id":8130514,"accession":"0001689375-23-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000042","line_url":"/filing/0001689375-23-000042#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":14.9357,"price_display":"14.94","price_state":"stated","total_value":132703.6945,"total_display":"132,703.69","total_whole":"132,704","shares_owned_after":49570.0,"shares_owned_after_display":"49,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":6525452,"accession":"0001689375-22-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000040","line_url":"/filing/0001689375-22-000040#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":24.0453,"price_display":"24.05","price_state":"stated","total_value":50495.13,"total_display":"50,495.13","total_whole":"50,495","shares_owned_after":45283.0,"shares_owned_after_display":"45,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6260458,"accession":"0001689375-22-000038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-22-000038","line_url":"/filing/0001689375-22-000038","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9348.0,"shares_display":"9,348","price_per_share":20.773537740693197,"price_display":"20.77","price_state":"stated","total_value":194191.0308,"total_display":"194,191.03","total_whole":"194,191","shares_owned_after":48283.0,"shares_owned_after_display":"48,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider","n_lines":3},{"id":6662005,"accession":"0001689375-22-000036","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-22-000036","line_url":"/filing/0001689375-22-000036","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2404.0,"shares_display":"2,404","price_per_share":19.301937770382697,"price_display":"19.30","price_state":"stated","total_value":46401.8584,"total_display":"46,401.86","total_whole":"46,402","shares_owned_after":56731.0,"shares_owned_after_display":"56,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-24","scope":"insider","n_lines":2},{"id":6661999,"accession":"0001689375-22-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000036","line_url":"/filing/0001689375-22-000036#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2771.0,"shares_display":"2,771","price_per_share":18.285,"price_display":"18.28","price_state":"stated","total_value":50667.735,"total_display":"50,667.74","total_whole":"50,668","shares_owned_after":59135.0,"shares_owned_after_display":"59,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-24","scope":"insider"},{"id":6661996,"accession":"0001689375-22-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000036","line_url":"/filing/0001689375-22-000036#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":905.0,"shares_display":"905","price_per_share":18.0735,"price_display":"18.07","price_state":"stated","total_value":16356.5175,"total_display":"16,356.52","total_whole":"16,357","shares_owned_after":61906.0,"shares_owned_after_display":"61,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-24","scope":"insider"},{"id":6136033,"accession":"0001689375-22-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000032","line_url":"/filing/0001689375-22-000032","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1544.0,"shares_display":"1,544","price_per_share":15.449181023316061,"price_display":"15.45","price_state":"stated","total_value":23853.5355,"total_display":"23,853.54","total_whole":"23,854","shares_owned_after":63026.0,"shares_owned_after_display":"63,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-28","scope":"insider","n_lines":2},{"id":6584201,"accession":"0001689375-22-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000029","line_url":"/filing/0001689375-22-000029#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018.0,"shares_display":"1,018","price_per_share":15.0694,"price_display":"15.07","price_state":"stated","total_value":15340.6492,"total_display":"15,340.65","total_whole":"15,341","shares_owned_after":64355.0,"shares_owned_after_display":"64,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-23","scope":"insider"},{"id":6584198,"accession":"0001689375-22-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000029","line_url":"/filing/0001689375-22-000029#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3275.0,"shares_display":"3,275","price_per_share":15.1258,"price_display":"15.13","price_state":"stated","total_value":49536.995,"total_display":"49,537.00","total_whole":"49,537","shares_owned_after":65373.0,"shares_owned_after_display":"65,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider"},{"id":6464711,"accession":"0001689375-22-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000027","line_url":"/filing/0001689375-22-000027#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":15.01,"price_display":"15.01","price_state":"stated","total_value":1501.0,"total_display":"1,501.00","total_whole":"1,501","shares_owned_after":68648.0,"shares_owned_after_display":"68,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6104570,"accession":"0001689375-22-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-22-000018","line_url":"/filing/0001689375-22-000018#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":865.0,"shares_display":"865","price_per_share":15.0646,"price_display":"15.06","price_state":"stated","total_value":13030.879,"total_display":"13,030.88","total_whole":"13,031","shares_owned_after":68748.0,"shares_owned_after_display":"68,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-09","filed_date":"2022-09-12","scope":"insider"},{"id":6104567,"accession":"0001689375-22-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-22-000018","line_url":"/filing/0001689375-22-000018#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":912.0,"shares_display":"912","price_per_share":15.1472,"price_display":"15.15","price_state":"stated","total_value":13814.2464,"total_display":"13,814.25","total_whole":"13,814","shares_owned_after":69613.0,"shares_owned_after_display":"69,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6214727,"accession":"0001104659-22-075788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-075788","line_url":"/filing/0001104659-22-075788#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873392","owner_name":"Dowden Nathan J","owner_display_name":"Dowden Nathan J","owner_url":"/insider/0001873392","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7714.0,"shares_display":"7,714","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":100282.0,"total_display":"100,282.00","total_whole":"100,282","shares_owned_after":64893.0,"shares_owned_after_display":"64,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Officer (President & COO)","n_filings":17,"first_seen":"2022-06-29","last_seen":"2026-05-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001873392","retrieved_at":"2026-08-22T08:41:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}